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Occlusions With the New Outback Catheter Following
Failed Conventional Endovascular Intervention
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Ralph Kickuth, MD3; Iris Baumgartner, MD1; and Dai-Do Do, MD1
1Cardiovascular Department, Clinical and Interventional Angiology, 2Vascular Surgery,
and 3Department of Radiology, University Hospital Berne and University of Berne,
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¤ ¤
Purpose: To report the application of a true lumen re-entry device in the bailout treatment of
chronic total occlusions (CTO) of the superficial femoral artery (SFA) after failed angioplasty.
Methods: Nineteen patients (12 men; mean age 81 years, range 61–97) with 20 SFA CTOs
and Rutherford category 2 to 5 ischemia were prospectively evaluated. All CTOs had
unsuccessful recanalization using conventional techniques and were subsequently treated
with the Outback LTD catheter. Follow-up at 3, 6, and 12 months included ankle/toe
pressure measurement and pulse volume recordings. Endpoints were revascularization
rate, target lesion revascularization, and limb salvage.
Results: Revascularizationwasachieved in95%of thecases.Therewere2 (10%)periprocedural
complications unrelated to the re-entry device, which were resolved by endovascular or
surgical treatment.The target lesion revascularization rate was 10%, with the 2 eventsoccurring
at 3 and 6 months, respectively, in patients with Rutherford category 4–5 ischemia. There was
one below-the-knee amputation in the patient with failed revascularization.
Conclusion: The acute failure of endovascular treatment of SFA CTOs is most often due to
an inability to re-enter the true lumen after the occlusion is crossed in a subintimal plane.
Bailout revascularization with the Outback LTD catheter is highly successful and shows a
low device-related complication rate. This needle- and fluoroscopic-based re-entry device
increases the endovascular success rate and is therefore expanding the minimally invasive
treatment options for surgically unfit patients.
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Endovascular management of chronic total
occlusion (CTO) is not feasible in up to 25% of
the cases depending on the length and
calcification of the occluded segment.1 In
calcified CTOs, recanalization is frequently
performed over the subintimal route.2 Re-
entry of the guidewire into the true lumen is
the keystone of success and a main cause of
failure in these subintimal procedures. How-
ever, in some cases, true lumen re-entry is not
achieved until subintimal passage to a site far
from the level of vessel lumen patency,
leading to possible potential damage of side
branches or vessel segments suitable for
distal anastomosis of a potential bypass.
Therefore, two different guidance techniques
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for needle catheter systems have been devel-
oped to facilitate true lumen re-entry: intravas-
cular ultrasound (IVUS) and fluoroscopy.1,3,4
IVUS navigation, which is available with the
Pioneer catheter, is more expensive and de-
mands an ultrasound console as well as
additional skills, whereas the Outback catheter
allows direct fluoroscopic navigation. Early
studies using the Outback Catheter system
reported an inadequate technical success rate,
especially in calcified occlusions,4 so the
design was re-engineered to incorporate a
stiffer needle and a lateral exit port.
We report our first consecutive series of
endovascular treatments using the new Out-
back LTD re-entry catheter system as a bailout
procedure in patients with CTOs in the
superficial femoral artery (SFA).
METHODS
Patient Population
A study was conducted under Institutional
Review Board approval to retrospectively
review all patients who had bailout endovas-
cular treatment with the Outback LTD catheter
(Cordis, a Johnson & Johnson company,
Miami Lakes, FL, USA) from December 2006
to December 2007. All patients had given
informed consent before the procedure and
had SFA CTOs in which standard catheter and
guidewire techniques had failed. Interroga-
tion of the department’s prospectively main-
tained database identified 19 patients (12
men; mean age 81 years, range 61–97) with
20 SFA CTOs (Table 1) treated with the
Outback catheter system in this time period.
Data were gathered on demographic and
baseline characteristics, clinical presentation,
imaging studies, treatment modality, and
prospective follow-up at 3, 6, and 12 months.
Vascular Assessment and Follow-up
Assessment of peripheral circulation was
performed at baseline and at every follow-up
visit using noninvasive vascular tests that
included measurement of the systolic blood
pressure of both the anterior and posterior
tibial arteries and calculation of the ankle-
brachial index (ABI). Photoplethysmography to
measure great toe pressures was used in
arteries that were considered incompressible
(ABI .1.3) or in which oscillometric readings
showed poor pulsatility despite absolute ankle
pressures .50 mmHg. Imaging studies with
duplex ultrasound or angiography were com-
pleted in all patients at baseline and during
follow-up in cases in which recurrent stenosis
or occlusion or additional arterial lesions were
suspected clinically or hemodynamically.
Subintimal Re-Entry Procedure
Arterial access was either retrograde cross-
over or antegrade femoral. All patients were
systemically heparinized before the CTO was
manipulated. CTOs (Fig. 1A) were crossed
with either a hydrophilic 0.035-inch guidewire
(Radifocus; Terumo GmbH, Wettingen, Swit-
zerland) or a 0.018-inch Control wire (Boston
Scientific, Natick, MA, USA). Additional sup-
port catheters were used as needed. Occa-
sionally, balloon angioplasty in a segment of
the occlusion was required to facilitate navi-
gation through the remaining occlusion
(Fig. 1B). No standard technique was used
¤ ¤
TABLE 1
Clinical Characteristics of 19 Patients With 20
Chronic Total SFA Occlusions
Age, y 81 (61–97)
Men 12 (60%)
Body mass index, kg/m2 24.064.4
Hypertension 17 (89%)
Diabetes mellitus 3 (6%)
Dyslipidemia 12 (67%)
Smoking 9 (50%)
Coronary artery disease 8 (44%)
Cerebrovascular disease 1 (6%)
Rutherford category
2–3 4 (20%)
4 2 (10%)
5 14 (70%)
Occlusion length, cm 17 (5–40)
TASC lesion class
C 16 (80%)
D 4 (20%)
De novo lesion 17 (85%)
Recurrent occlusion after PTA 3 (15%)
¤ ¤
Continuous data are presented as means 6
standard deviation or (range); categorical data
are given as counts (percentages).
TASC: TransAtlantic Inter-Society Consensus,
PTA: percutaneous transluminal angioplasty.
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to intentionally place the wire subintimally;
however, subintimal passage was assumed in
all of the CTO crossings, which required the
use of true lumen re-entry maneuvers and
devices. Attempts to gain access to the true
lumen with catheter wire manipulations were
routinely made using additional catheters and
wires with different tip configurations. If these
attempts to access the true lumen failed, the
Outback LTD catheter true lumen re-entry
device was used.
The Outback LTD re-entry catheter is a
single-lumen, over-the-wire, 6-F sheath–com-
patible catheter with a curved nitinol cannula
within the outer shaft running the full length of
the catheter to serve as the guidewire lumen. In
contrast to the first-generation device, the new
catheter has an end port and a lateral exit port.
The nosecone at the catheter tip possesses an
L-shaped radiopaque marker indicating needle
direction. When the image intensifier is or-
thogonally moved, a ‘‘T’’ shape appears to
check whether the catheter is overlying the
artery to confirm alignment of the catheter to
the artery. Guiding the catheter proximally or
distally in the coaxial direction over a 0.014-
inch guidewire allows positioning at the de-
sired re-entry level. After assuring that the
catheter is ‘‘in line’’ with the vessel (T-marker
‘‘on top’’ of the artery) and that the cannula is
pointing toward the target lumen (shown by L-
marker when the image intensifier is turned by
90u), the 0.014-inch guidewire is retracted. The
curved cannula tip is deployed from the
catheter’s lateral exit port through the intima
into the true lumen. Upon proper placement of
the needle tip, the parked guidewire is ad-
vanced through the curved cannula tip into the
true lumen. Afterward, the cannula tip and
subsequently the Outback LTD catheter can be
removed, leaving the guidewire in place
(Fig. 2A). After successful controlled re-entry
is achieved, angioplasty and stenting can be
performed over the 0.014-inch guidewire or
over an exchanged 0.018-inch wire. In our
series, all femoral artery occlusions were
dilated and provisionally stented with self-
expanding nitinol stents (Fig. 2B). All patients
were treated with dual antiplatelet therapy
(100-mg/d aspirin and 75-mg/d clopidogrel)
for a minimum of 4 weeks.
Endpoint and Outcome Analysis
The primary endpoint was revascularization
success; secondary endpoints were the anal-
ysis of repeated lesion revascularization
(TLR), minor and major amputation, and
minor and major complications. To document
immediate hemodynamic success, clinical
Figure 1¤ (A) Angiogram showing a 15-cm-long
occlusion of the SFA. (B) Predilation (3-340-mm
balloon) to facilitate subintimal passage of the
Outback LTD catheter to the re-entry target at the
36-cm level on the popliteal artery.
Figure 2¤ (A) Needle deployment (arrow) and a
0.014-inch guidewire advanced through the needle
into the proximal patent popliteal artery. (B) Final
angiogram after stenting of the superficial
femoral artery.
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evaluation and ABI or toe pressure measure-
ments were performed 12 to 36 hours after
endovascular treatment. Primary technical
success was determined as true lumen ac-
cess, whereas revascularization success en-
compassed an open femoropopliteal axis on
angiography, with hemodynamic improve-
ment of at least 0.1 for the ABI or 10 mmHg
in the toe pressure.
Peri- and postinterventional complications
were classified according to the reporting
standards5 of the Society of Interventional
Radiology and were documented up to
30 days. Minor complications were classified
as (A) those requiring no therapy and having
no consequence or (B) those having nominal
therapy and no consequence (including over-
night admission for observation only). Major
complications were divided into 4 classes: (C)
requiring therapy and/or short (,48 hours)
hospitalization; (D) requiring major therapy,
unplanned increase in the level of care, or
prolonged (.48 hours) hospitalization; (E)
resulting in permanent adverse sequelae; or
(F) resulting in death.
Statistical Analysis
For continuous variables, values are given
as either the mean with range or standard
deviation or as the median with interquartile
range (IQR) as indicated. For discrete vari-
ables, data are presented as the counts
(percentages). The Wilcoxon signed rank test
was used for comparison of pre- and post-
interventional ABIs and toe pressures.
RESULTS
A femoral crossover technique was used in
60% of the revascularization procedures,
which were successful in 19 (95%) of 20
lesions on an intention-to-treat basis. In the
failed case, the device could not be removed
and leave the guidewire in place due to
kinking in a crossover access. Subsequently,
the true lumen access was lost due to
retraction of the kinked guidewire. This
patient was considered unfit for bypass
surgery and underwent below-the-knee am-
putation; he died 1 month later due to cardiac
insufficiency.
One patient needed additional abciximab
therapy due to intravascular thrombosis dur-
ing the procedure, which was concluded
successfully. The median baseline ABI was
0.37 (IQR 0.25–0.5), and the median toe
pressure was 25 mmHg (IQR 5–30); both
increased significantly (p,0.0001) after revas-
cularization to 0.87 (IQR 0.82–1.03) and
37 mmHg (IQR 30–50), respectively (Fig. 3).
Periprocedural Complications
There were 2 (10%) major complications
not related to the re-entry device requiring
additional interventions. In one case involv-
ing a crossover access for the treatment of a
left femoral CTO, plaque dislocation occurred
at the right femoral sheath insertion site, with
Figure 3¤Median and interquartile ranges of
ankle-brachial indexes (A) and toe pressures (B)
at baseline and after subintimal bailout revascu-
larization with the Outback LTD catheter. Toe
pressure was taken in presence of incompressible
tibial arteries. *p,0.0001.
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subsequent SFA occlusion (complication cat-
egory C). This complication was managed
with a crossover stenting maneuver and had
no further sequelae. In the other case, which
involved an antegrade access, distal emboli-
zation in a single runoff tibial artery was
managed successfully by catheter-based as-
piration (complication category C). Neither
vessel perforation nor laceration due to the
needle catheter system occurred.
Follow-up and TLR
Walking capacity was re-established in 4
patients treated for Rutherford category 2–3
claudication (Table 2). Clinical improvement
was sustained up to a mean follow-up of
6 months, and there were no TLRs up to this
point. One patient had a binary restenosis
.50% on ultrasound examination at 6 months
without recurrent claudication. Another pa-
tient had an asymptomatic segmental femoral
reocclusion at 12 months, but no TLR was
necessary.
In the 16 limbs with Rutherford category 4–
5 ischemia, the only major amputation was
the one involving the patient who had a failed
revascularization. Two (10%) TLRs were nec-
essary because of delayed wound healing.
One patient had a patent femoral artery at the
1-month follow-up (ABI 0.83), but the ABI was
reduced to 0.46 at 3 months, with evidence of
significant binary restenosis (.50%). In the
other patient, who had medial calcinosis and
prior traumatic forefoot amputation, rest pain
developed at 6 months owing to complete
reocclusion. Although wound healing was
not fully achieved at the 6- or 12-month
follow-up in both cases, no minor or major
amputations were necessary, and the rest
pain remained resolved.
DISCUSSION
At the beginning of the endovascular era, the
ability to treat CTOs was initially limited
primarily by failure to cross the occlusion. With
the development of stents to treat failed
angioplasty, the most common cause for acute
procedural failure in the treatment of CTOs has
become the inability to engage the true lumen
with the guidewire and/or support catheter after
recanalization. To overcome this technical
challenge, different re-entry catheters were
developed to allow passage of a guidewire into
the true lumen distal to the occlusion.1,6 We and
other groups previously reported the safe and
successful application of an IVUS-guided cath-
eter system (Pioneer) for steering the puncture
needle to create a re-entry into the true
lumen.1,6 This system requires a 7-F sheath, is
expensiveowing to the ultrasound console, and
demands additional specific skills, which could
limit the widespread use of the device. In
¤ ¤
TABLE 2
Follow-up Examinations, Recurrences, and Target Lesion Revascularizations
Baseline 1 Month 3 Months 6 Months 12 Months
Number of patients 19 15 14 14 6
Number of lesions 20 16 15 14 6
Rutherford 2–3
Examinations 4 9 12 11 5
Recurrence 0 0 1{ 11
Reintervention 0 0 0 0
Rutherford 4–5
Examinations 16 7 3 3 1
Recurrence 0 1* 1{ 0
Reintervention 0 1* 1{ 0
Amputation 1 0 0 0
¤ ¤
* Restenosis .50% in a 74-year-old man with a 5-cm occlusion at primary intervention.
{ Restenosis 50% in a 62-year-old woman with a 29-cm occlusion at primary intervention.
{ Complete reocclusion in a 65-year-old man with a 6-cm occlusion at primary intervention.
1 Segmental reocclusion in a 95-year-old man with a 30-cm occlusion at primary intervention.
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comparison, the Outback LTD catheter system
is compatible with a 6-F sheath and uses
fluoroscopic navigation that is readily available
in any catheterization laboratory or interven-
tional suite. Moreover, because no ultrasound
is used, the procedure is less expensive.
While the success rate of subintimal recan-
alization with standard technique is reported to
be up to 85%,7–9 revascularization success can
be improved to almost 100% by using re-entry
devices. However, heavily calcified lesions
limited the re-entry success rate to as low as
50% in early reports using the first-generation
Outback catheter.4 Therefore, the system was
redesigned to deploy the needle via a lateral
port from the integral hypotube that previous-
ly ended in a curved retractable needle.1,3,4
Using the redesigned system, we were able to
achieve a 95% revascularization rate with the
Outback LTD catheter in 20 cases of chronic
SFA occlusion. The uncontrolled needle de-
ployment and ineffective penetration of the
intima initially reported by Wiesinger et al.4 did
not occur with the new system in our series.
It usually took several attempts to enter and
track the 0.014-wire into the true lumen.
Kinking of the 0.014-inch wire should be
avoided because it might make it impossible
to keep the guidewire within the true lumen
while withdrawing the catheter system, espe-
cially in cases using crossover access. This
problem was the cause for our only failure
early in our learning curve. This obviously
represents a limitation of the Outback cathe-
ter involving crossover maneuvers in patients
with tight angulation of the aortic bifurcation.
Comparing fluoroscopy guidance to IVUS
navigation, the presence of calcium can limit
IVUS imaging, but on the other hand, its
presence is an important vessel characteristic
for steering the Outback LTD catheter. Al-
though calcium might be a limitation to
needle deployment through the intima, all of
the cases in our series had severe vessel
calcification but were successfully treated.
Calcifications may impose an obstacle to
catheter advancement through the subintimal
space, but this could be resolved with balloon
predilation using low-profile catheters. Calci-
fications might even improve the accuracy of
achieving true lumen re-entry at the point
desired, which is an advantage that was not
fully recognized before our experience with this
new re-entry device. For example, in an SFA
occlusion, precise positioning of the re-entry in
a reconstituted above-knee popliteal artery may
preserve the option of an above-knee femoro-
popliteal bypass in the event of long-term
failure of angioplasty or stenting. Furthermore,
the availability of true lumen re-entry devices
will broaden the applicability of endovascular
recanalization techniques to poor-surgical-risk
patients with more severe disease, i.e., elderly
patients with critical limb ischemia. Although
the application of this needle catheter has been
shown to be safe, the potential for perforation
and severe bleeding from the puncture side has
to be taken into account, and appropriate
covered stents should be available when using
a needle re-entry system.
Compared to previous reports, the re-entry
success rate in our study is improved with the
re-engineered system.1,3,4 Hausegger et al.3
used the first-generation model of the Out-
back system in 10 patients with intermittent
claudication as a bailout procedure to cross
iliofemoral lesions; they reported a success
rate of 80%. Using the same model, Wie-
singer et al.4 reported a success rate of only
50%. The low success rate was attributed to
insufficient stiffness and sharpness of the
system for penetrating, crossing, and punc-
turing. In addition, Jacobs et al.1 reported a
failure of 26% with conventional guidewires
and guiding catheters in a series of 87
iliofemoral CTOs. In 3 cases, they used the
Outback catheter system with 100% success;
the other 21 cases were treated with the
Pioneer catheter. Compared to the original
Outback catheter, the new Outback LTD
catheter can be used safely even with a stiffer
needle that potentially increases the success
rate. In our series, there were no complica-
tions related to the new needle system.
As regards TLR, our series demonstrated
favorable short-term follow-up, with a 10% TLR
rate compared to other studies reporting TLR
rates between 30% to 75%.7,9 There were 2
significant but asymptomatic restenoses that
will, over time, decrease the patency rate and
increase the need for vascular follow-up and
reintervention depending on the clinical stage.
However, although application of the re-entry
catheter increases the revascularization suc-
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cess rate, recurrent stenosis or occlusion
remains a limitation, especially in de novo
long occluded segments. Therefore, the eval-
uation of re-entry catheters must be based on
clinical stages and lesion characteristics, as
well as a relationship to patency prognosis. In
critically ischemic limbs, the higher costs
associated with re-entry catheters seem justi-
fied, whereas in claudicants, the overall and
long-term clinical benefits may not necessarily
outweigh additional costs.
Conclusion
The fluoroscopically-navigated Outback LTD
needle re-entry system is safe, easy to use,
and very effective. It represents the device of
first choice as a bailout endovascular option
for femoral CTOs in patients with either
claudication or critical limb ischemia. Short-
and midterm sustained clinical improvement
appears favorable.
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